• Gene deletion; HGNC; 11103; SMARCB1; Zygosity=Homozygous (PubMed=32359397).
  

PubMed=28753786; DOI=10.1016/j.euf.2016.08.005; PMCID=PMC5608640
Dong Y.-Y., Manley B.J., Becerra M.F., Redzematovic A., Casuscelli J., Tennenbaum D.M., Reznik E., Han S., Benfante N.E., Chen Y.-B., Arcila M.E., Aras O., Voss M.H., Feldman D.R., Motzer R.J., Fabbri N., Healey J.H., Boland P.J., Chawla M., Durack J.C., Lee C.-H., Coleman J.A., Russo P., Hakimi A.A., Cheng E.H., Hsieh J.J.-D.
Tumor xenografts of human clear cell renal cell carcinoma but not corresponding cell lines recapitulate clinical response to sunitinib: feasibility of using biopsy samples.
Eur. Urol. Focus 3:590-598(2017)

PubMed=32359397; DOI=10.1016/j.ccell.2020.04.002; PMCID=PMC7288373
Msaouel P., Malouf G.G., Su X.-P., Yao H., Tripathi D.N., Soeung M., Gao J.-J., Rao P., Coarfa C., Creighton C.J., Bertocchio J.-P., Kunnimalaiyaan S., Multani A.S., Blando J., He R., Shapiro D.D., Perelli L., Srinivasan S., Carbone F., Pilie P.G., Karki M., Seervai R.N.H., Vokshi B.H., Lopez-Terrada D.H., Cheng E.H., Tang X.-M., Lu W., Wistuba I.I., Thompson T.C., Davidson I., Giuliani V., Schlacher K., Carugo A., Heffernan T.P., Sharma P., Karam J.A., Wood C.G., Walker C.L., Genovese G., Tannir N.M.
Comprehensive molecular characterization identifies distinct genomic and immune hallmarks of renal medullary carcinoma.
Cancer Cell 37:720-734.e13(2020)